Dear NEMO Collaborators,

Welcome to the fifth edition of the NEMO newsletter. So much has been happening quietly behind the scenes since the last edition. We bid farewell to O4CP, who exited the consortium last November, and also completed the Trial Master File and Investigator Site Files thus marking the final step in whipping into shape the NEMO-1 documentation. We would like to thank all the PIs, investigators and study team for the hard work involved. Can we ask to join with us in welcoming to the NEMO project UPharma as our new pharmaceutical partner.The amendment of the NEMO project Technical Annex was been submitted to the EU for consideration and comment and we hope that UPharma's position in NEMO will be official shortly.

Best Wishes
Geraldine and Ronit
Rate: 12345 (0) | Facebook Twitter LinkedIn Del.icio.us Digg | View Comments (0)
Post a comment


In This Issue
Partner News
NEMO publications
Project updates
Feature Story
News and Views
NEMO in the news
Some recent publications
As usual the NEMO collaborators have been a busy group.....
Read more
Useful Links
Nemo Europe
NEMO Study
Seventh Framework Programme

NEMO is a Collaborative Project funded by the European Commission under the 7th Framework Programme
Email Newsletter Software by Newsweaver